Bumper Offer - Urjas oil Just @ Rs. 1
Clopitab CV Gold Capsule is a commercial drug that is prescribed in the form of Capsule. The alternative uses of Clopitab CV Gold Capsule have also been explained below.
The correct dosage of Clopitab CV Gold Capsule depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Clopitab CV Gold Capsule are Headache, Nasopharyngitis, Diarrhoea. Apart from the aforementioned side effects, Clopitab CV Gold Capsule can also lead to other problems, which have been listed below. Normally, these side effects of Clopitab CV Gold Capsule are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Clopitab CV Gold Capsule's effect during pregnancy is Moderate and Mild while nursing. Further, the section on Clopitab CV Gold Capsule related warnings talks about Clopitab CV Gold Capsule's effects on the liver, heart and kidney.
Clopitab CV Gold Capsule is contraindicated in people with pre-existing medical conditions like Liver Disease, Alcoholism, Bleeding as it can result in adverse effects. Other contraindications of Clopitab CV Gold Capsule have been discussed in the sections ahead.
Drug reaction of Clopitab CV Gold Capsule with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Clopitab CV Gold Capsule is safe while driving, and is is addictive in nature.
Clopitab CV Gold Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Clopitab CV Gold Capsule safe for pregnant women?
Clopitab Cv can have harmful effects in pregnant women. If you experience any discomfort after using Clopitab Cv, then discontinue the use and take your doctor's advice.
Is the use of Clopitab CV Gold Capsule safe during breastfeeding?
Clopitab Cv may have very limited harmful effects for breastfeeding women.
What is the effect of Clopitab CV Gold Capsule on the Kidneys?
Clopitab Cv rarely harms the kidneys.
What is the effect of Clopitab CV Gold Capsule on the Liver?
You may experience side effects on your liver after taking Clopitab Cv. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Clopitab CV Gold Capsule on the Heart?
Clopitab Cv has very mild side effects on the heart.
Clopitab CV Gold Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Clopitab CV Gold Capsule unless your doctor advises you to do so -
Is this Clopitab CV Gold Capsule habit forming or addictive?
Clopitab CV Gold Capsule is not addictive in nature.
Interaction between Food and Clopitab CV Gold Capsule
Eating certain foods may increase the time it takes Clopitab CV Gold Capsule to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Clopitab CV Gold Capsule
Information about the interaction of Clopitab CV Gold Capsule and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
